Centrosome defects are observed in a broad array of solid and liquid tumors and are associated with advanced disease and poor patient prognosis. Unexpectedly, centrosome aberrations are present in only a subset of cells within a tumor and are poorly tolerated in non‐transformed cells, raising the conundrum of why centrosome aberrations are maintained during tumor evolution. New work by Ganier et al published in The